As of 2025-07-11, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (185.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.79 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -2212.3%.
The range of the Relative Valuation is (122.04) - (237.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 27.2x | 20.3x |
| Forward P/E multiples | 14.0x - 30.6x | 22.3x |
| Fair Price | (122.04) - (237.10) | (185.67) |
| Upside | -1488.4% - -2797.4% | -2212.3% |
| Date | P/E |
| 2025-07-10 | -1.01 |
| 2025-07-09 | -0.99 |
| 2025-07-08 | -0.95 |
| 2025-07-07 | -0.86 |
| 2025-07-03 | -0.90 |
| 2025-07-02 | -0.84 |
| 2025-07-01 | -0.85 |
| 2025-06-30 | -0.83 |
| 2025-06-27 | -0.83 |
| 2025-06-26 | -0.82 |
| 2025-06-25 | -0.88 |
| 2025-06-24 | -0.95 |
| 2025-06-23 | -0.82 |
| 2025-06-20 | -0.87 |
| 2025-06-18 | -0.96 |
| 2025-06-17 | -0.86 |
| 2025-06-16 | -0.92 |
| 2025-06-13 | -0.88 |
| 2025-06-12 | -0.92 |
| 2025-06-11 | -0.91 |
| 2025-06-10 | -0.84 |
| 2025-06-09 | -0.82 |
| 2025-06-06 | -0.83 |
| 2025-06-05 | -0.69 |
| 2025-06-04 | -0.72 |
| 2025-06-03 | -0.68 |
| 2025-06-02 | -0.60 |
| 2025-05-30 | -0.61 |
| 2025-05-29 | -0.66 |
| 2025-05-28 | -0.66 |
| 2025-05-27 | -0.64 |
| 2025-05-23 | -0.63 |
| 2025-05-22 | -0.65 |
| 2025-05-21 | -0.65 |
| 2025-05-20 | -0.70 |
| 2025-05-19 | -0.68 |
| 2025-05-16 | -0.67 |
| 2025-05-15 | -0.67 |
| 2025-05-14 | -0.64 |
| 2025-05-13 | -0.68 |
| 2025-05-12 | -0.65 |
| 2025-05-09 | -0.51 |
| 2025-05-08 | -0.56 |
| 2025-05-07 | -0.50 |
| 2025-05-06 | -0.53 |
| 2025-05-05 | -0.58 |
| 2025-05-02 | -0.64 |
| 2025-05-01 | -0.69 |
| 2025-04-30 | -0.64 |
| 2025-04-29 | -0.60 |